Rhumbline Advisers Avita Medical, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Avita Medical, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 42,168 shares of RCEL stock, worth $232,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,168
Previous 38,775
8.75%
Holding current value
$232,767
Previous $315,000
29.21%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RCEL
# of Institutions
85Shares Held
7.6MCall Options Held
46.5KPut Options Held
18.5K-
Black Rock Inc. New York, NY1.78MShares$9.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$8.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA618KShares$3.41 Million0.0% of portfolio
-
State Street Corp Boston, MA529KShares$2.92 Million0.0% of portfolio
-
Ubs Group Ag410KShares$2.26 Million0.0% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $138M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...